Value-based care is changing the dialysis landscape. No longer are the major costs associated with access complications such as hospitalizations and a new access placement the responsibility of the payer. With upwards of 15% to 20% of hospitalizations due to access-related issues, prevention of thrombosis that can lead to access loss becomes very important. Our white paper estimated the costs of a single reversion at more than $26,000.
The key to keeping patients out of the hospital and on their existing AV access is to prevent thrombosis in the first place. Vasc-Alert does this by presenting actionable reports every week on the patients most at-risk for complications so that staff can then investigate further those high-risk patients for possible referral. Saving even one patient’s access by making a timely referral avoids the expenses related to an access reversion and more than covers the cost of Vasc-Alert service for the entire facility.
If your facility is not yet engaged in a value-based program, Vasc-Alert can still pay for itself by reducing missed treatments and catheter use when patients do lose the use of their AV access. Also, by beginning now to improve the access care of your patients, your facility will be all that more prepared for participating in value-based programs.
About the Vasc-Alert Subscription
Vasc-Alert is offered for a nominal yearly subscription based on the number of AV access patients in the facility. Included are the training of users and ongoing clinical support, weekly and monthly reports, access to training podcasts, and in-depth analysis of your results upon request. For organizations involved in value-based contracts, Vasc-Alert is open to discussing entering a risk-based relationship as a vendor.